Health Secretary Robert F. Kennedy Jr. is getting rid of all members sitting on a key U.S. Centers for Disease Control and ...

Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...

The Trump administration’s decision to pull the Covid-19 vaccine from the CDC’s list of recommended shots for healthy ...

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

announced today that a US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) discussed the supplemental Biologics License Application (sBLA) for Columvi® (glofitamab) in ...

The voting members of the FDA’s Vaccine and Related Biological Products Advisory Committee agreed that next respiratory season’s shots should target the JN.1 family of viruses. - Sergio Flores ...

The panel's meeting is ... The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026. "We are ...

An FDA advisory committee unanimously recommended ... 1 lineage of the Omicron variant. During the meeting, committee members heard presentations by all three of the current vaccine manufacturers ...

Several of the committee members asked at Thursday’s meeting ... FDA’s Office of Vaccines Research and Review. The voting members of the FDA’s Vaccine and Related Biological Products ...

The panel's meeting is routine ... from an independent panel. "The FDA and the CDC typically rely on the advice of independent advisory committees, and I think that's what would have been ideal ...

An FDA advisory committee will meet Thursday to discuss changes to the COVID-19 vaccine formula. Leaders will hear from scientists and doctors at the Centers for Disease Control and Prevention plus ...